Esperto Medical

Esperto Medical is a private, pre-revenue startup based in San Francisco, founded in 2021, targeting the digital health and AI/machine learning sectors. The company's primary innovation is a non-invasive, continuous blood pressure monitor that uses ultrasound-based Resonance Sonomanometry™ (RSM), which requires no calibration and works across all skin tones and patient demographics. Its wearable device is designed for 24/7 use in clinical and research settings, with the goal of enabling proactive care, improving patient outcomes, and reducing costs associated with invasive monitoring. Esperto is currently conducting clinical studies and is not yet commercially available.

Resonance Sonomanometry™ (RSM) - An ultrasound-based technology that uses multiple frequency bands to measure artery shape and resonant frequencies to directly calculate arterial tension and blood pressure without calibration.

Esperto competes in the non-invasive continuous blood pressure monitoring space against large players like Philips and Edwards Lifesciences, as well as other startups using technologies like photoplethysmography (PPG) with AI, tonometry, and other methods. Its key differentiator is its calibration-free, ultrasound-based RSM technology which claims immunity to skin-tone bias—a known limitation of dominant optical (PPG) approaches.